NPLB – Atharva Tyagi

No Patient Left Behind (NPLB)

No Patient Left Behind (NPLB) Biotech Fellowship

Overview

Selected as one of a handful of fellows in the No Patient Left Behind Biotech Fellowship, a national program bringing together graduate students, industry professionals, and policy experts to explore the intersection of healthcare access, drug development, and regulation. I was the only high school fellow among more than 250 participants from leading universities and companies, learning directly from executives, researchers, and policymakers shaping the future of biotech and health equity.

Focus

Through lectures, case studies, and collaborative projects, I gained a comprehensive view of how therapies move from discovery to distribution. The fellowship emphasized understanding insurance systems, FDA pathways, and reimbursement frameworks to make treatments more affordable and accessible for patients with rare and chronic diseases.

Access for All Project

Worked with a Stanford researcher and a team of professionals on “Data-Driven Advocacy: Making Rare Disease Trials More Accessible.” The project used data visualization and patient-centered storytelling to identify barriers to clinical trial participation and propose policy recommendations for expanding access.

Reflection

The NPLB Fellowship was a defining experience because it placed me in the same room as leaders I had only read about and challenged me to think at their level. Listening to CEOs, scientists, and policymakers discuss the real constraints behind drug pricing and access gave me a front-row view of how systemic change happens. As the only high school fellow, I learned how to translate scientific ideas into policy and business language, and how to advocate for patients through both data and empathy. It reinforced why I want to build a career at the intersection of discovery, economics, and care: where innovation only matters as long as no patient is left behind.